-
ALSO READ
Johnson & Johnson starts two-dose trial of its Covid-19 vaccine candidate
Australian varsity develops blood test to trace coronavirus in 20 minutes
A jab at risk: Serum's quest to lead the world in Covid-19 vaccine race
Next big bet: Experts bullish on Bharat Biotech's upcoming nasal vaccine
Covid-19 vaccines raise hope for cancer, throw open new field of medicine
-
The World Health Organisation and partners said on Tuesday they are creating a global stockpile of Ebola vaccines to help stamp out future outbreaks.
In a statement, WHO, Doctors Without Borders, UNICEF and the International Federation of Red Cross and Red Crescent Societies said they were establishing an emergency reserve of about 500,000 doses; nearly 7,000 are available now and more will be added throughout the year and beyond. Financial support for the vaccine stockpile was provided by the vaccines alliance GAVI.
The Ebola vaccine being stockpiled is made by Merck. Before it was licensed, the shot was used to previously help contain outbreaks in Guinea and Congo under a protocol for compassionate use.
Other stockpiles managed by WHO and partners exist for diseases including meningitis and yellow fever.
The Ebola vaccines will be stored in Switzerland, where they will be ready to be shipped after WHO and partners receive a request from countries. The agencies say any decision to release vaccines will be made within 48 hours of any such request and that the targeted delivery time is within one week.
The vaccines will be reserved for those at highest risk of being infected with Ebola during any epidemic, including those exposed to the disease and health workers treating patients and their contacts.
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU